NEWTON, Mass.--(BUSINESS WIRE)--Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced it has entered into a collaboration with Mayo Clinic to ...
Implementing an automated urinary incontinence screening and education program in primary care practices significantly increased awareness and treatment referrals in women with the condition, ...
TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results